Table 1 Pulmonary function tests for the evaluation of COPD patients.

From: Pulmonary function testing in COPD: looking beyond the curtain of FEV1

Pulmonary function test

Indicator of airflow limitation

Advantages

FEV1/FVC

Decreased FEV1/FVC

Decreased FEV1

Gold-standard

Reflects severity of airflow limitation.

Flow-volume curve

Scooping

First indication of small airway obstruction in patients with normal FEV1.

Effective in differentiating between healthy adults and patients with mild COPD.

PEFR

A PEFR of < 80% predicted detects airflow limitation (90% sensitivity, 50% specificity)

PEFR measurements alone cannot reliably be used as the only diagnostic test for COPD due to the weak specificity. A potential monitoring tool

PIFR

No clear correlation between airflow limitation or FEV1 and PIFR

PIFR is related to optimal drug delivery with dry powder inhalers used to treat COPD. It can be reduced at the time of COPD exacerbation.

Resting lung volumes and capacities

Decreased IC

May indicate flow limitation even in patients with milder disease, in whom FEV1 is preserved.

Resting IC may predict patients’ tolerance to exercise.

IC/TLC is a predictor of mortality and respiratory failure.

Specific airway resistance (Sraw)

Breathing loops

Increased specific airway resistance

Flattening and open appearance

Opening in breathing loops indicate airway obstruction, trapped air, and it has been significantly associated with RV/TLC ratio.

DLCO

Low DLCO

Indicative of emphysema.

Predictor of exertional hypoxemia.

KCO

Low KCO

KCO better reflects emphysema compared to DLCO. Predictor of COPD exacerbations and outcome

DLNO

Low DLNO

DLNO could be more sensitive in detecting alveolar destruction and emphysema than the DLCO or KCO.

Oscillometry

Increased expiratory Zrs

Can detect lung dysfunction in smokers, before any symptoms arise and small airway disease

Zrs correlates to the severity of airway narrowing.

More sensitive than FEV1 in detecting expiratory flow limitation.

Field exercise tests (6 MW test)

Decreased distance achieved

Representative of the day-to-day physical activity of the patients.

Correlates with mortality.

CPET

Combines various parameters measured during a symptom-limited exercise test (e.g., decreased VO2, decreased SpO2, decreased TV)

Adequately detects patients with mild airway obstruction but disproportionately severe dyspnea.

Can reveal dynamic physiological abnormalities in smokers with normal spirometry.

Anthropometry

Malnutrition

Sarcopenia (low muscle mass)

Correlate with the severity of airway obstruction.

Indicative of higher mortality.

MIP

Low MIP

Indicative of inspiratory muscle weakness

SMIF

Low SMIF

Associated with functional exercise capacity, dyspnea, airflow obstruction, greater hyperinflation, worse health and mental status and impaired quality of life

SNIP

Low SNIP

Impaired diaphragm activity and inspiratory accessory muscle dysgunction

Related to severity

Predictor of Mortality

MEP

Low MEP

Expiratory muscle weakness

  1. Table summarizing the available pulmonary function tests for the evaluation and classification of COPD patients.
  2. COPD Chronic Obstructive Pulmonary Disease, CPET Cardiopulmonary exercise testing, DLNO nitric oxide diffusing capacity, FEV1 Forced. Expiratory Volume in the first second, FVC Forced Vital Capacity, IC Inspiratory Capacity, KCO carbon monoxide transfer coefficient, MEP Maximal expiratory pressure, MIP Maximum inspiratory pressure, TLC Total Lung Capacity, DLCO Lung Diffusing Capacity for carbon monoxide, Zrs respiratory system impedance, 6MWT 6 min walking test, PEFR Peak expiratory flow rate, PIFR Peak inspiratory flow rate, SMIP Sustained maximal inspiratory pressure, SNIP Sniff nasal inspiratory pressure, VO2 respiratory oxygen uptake.